One hundred percent
The immunological effectiveness of the Epivaccorona vaccine according to the results of the first two phases of clinical trials is 100%.
19.01.2021The immunological effectiveness of the Epivaccorona vaccine according to the results of the first two phases of clinical trials is 100%.
19.01.2021The oxygen binding characteristics of artificial protein are similar to those of natural globins with distal histidines, except that molecular oxygen (O2) binds more strongly than carbon monoxide (CO). This property of the new protein can be very useful when creating artificial blood.
30.03.2009The first plant in Russia for the production of DNA analysis kits will open near Obninsk.
30.10.2018The House of Commons has approved a law allowing the creation of hybrid embryos. If the upper house makes a positive decision, the creation of chimeras in the UK may be allowed in November 2008.
23.10.2008Treatment for low-risk prostate cancer may do more harm than good, so active surveillance tactics are preferred in many cases
30.01.2024Researchers at the University of Liverpool have investigated how cross-modal connections between olfaction and vision manifest themselves
10.10.2023Components of brain cells formed in shallow water about 800 million years ago, researchers find
28.09.2023MIT has developed a miniaturized ultrasound scanner that allows imaging at any time
31.07.2023Researchers analyzed abdominal aortic calcinosis using a machine learning algorithm
19.07.2023The robotic complex can work in conjunction with any ultrasound machine that has the ability to save data in DICOM-format
06.07.2023Artificial organelles, if filled with a suitable set of enzymes, can also work in other human cells – and this opens up opportunities for a new type of anti-cancer therapy.
03.06.2008The Board of Directors of Rusnano will consider the issue of transferring the powers of the Chairman of the Management Board of Rusnano to the Rusnano Management Company, in which Anatoly Chubais will take the post of Chairman of the Management Board.
21.01.2014The Russian biopharmaceutical company Incuron has received FDA approval for clinical trials of the drug for the treatment of patients with progressive malignant tumors.
11.04.2013Russian companies and research institutes will be among the main participants of the International Forum-Exhibition on Biotechnologies BIO International Convention.
28.06.2011Russian business is not motivated to consume innovations. This opinion was expressed by the President of the Chamber of Commerce and Industry of the Russian Federation Sergey Katyrin, speaking at the international economic forum in Strasbourg, France.
28.06.2011You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.